Hepatitis B-related membranous nephropathy should be treated with a specific anti-viral agent

Kidney International

Volumn 70, Issue 4, 2006, Pages 818-

  Tang, S ^a   Lai, K N ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; LAMIVUDINE; PROTEIN; VIRUS DNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALBUMINURIA; ANTIBIOTIC RESISTANCE; DRUG WITHDRAWAL; HEPATITIS B; HUMAN; KIDNEY FIBROSIS; LETTER; LONG TERM CARE; MEMBRANOUS GLOMERULONEPHRITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; RELAPSE; REMISSION; RENAL REPLACEMENT THERAPY; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS RESISTANCE;

ANTIVIRAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, VIRAL; GLOMERULONEPHRITIS, MEMBRANOUS; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; RECURRENCE; REMISSION INDUCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 33747079514     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001586     Document Type: Letter

References (4)

1. Ng YY, Yang WC, Lee ST. Long-term lamivudine therapy in hepatitis B-associated membranous nephropathy? Kidney Int 2006; 69: 776.
2. Tang S, Lai FM, Lui YH et al. Lamivudine in hepatitis B-associated membranous nephropathy. Kidney Int 2005; 68: 1750-1758.
3. de Zeeuw D, Remuzzi G, Parving HH et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 2004; 65: 2309-2320.
4. Tang S, Leung JC, Abe K et al. Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest 2003; 111: 515-527.